Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
9.87
-0.09 (-0.90%)
Apr 17, 2026, 3:04 PM CST
SHE:300009 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 250.2 | 299.18 | 260.23 | 324.59 | 322.56 |
Short-Term Investments | 141.07 | - | - | - | - |
Trading Asset Securities | 1,192 | 1,145 | 1,196 | 842.91 | 805.43 |
Cash & Short-Term Investments | 1,583 | 1,444 | 1,456 | 1,167 | 1,128 |
Cash Growth | 9.65% | -0.82% | 24.70% | 3.50% | 26.10% |
Accounts Receivable | 495.56 | 492.35 | 597.44 | 476.3 | 543.89 |
Other Receivables | 35.16 | 30.54 | 9 | 11.25 | 46.96 |
Receivables | 530.73 | 522.9 | 606.44 | 487.55 | 590.85 |
Inventory | 252.75 | 297.3 | 235.22 | 210.48 | 181.25 |
Other Current Assets | 28.36 | 11.03 | 28.03 | 45.02 | 21.53 |
Total Current Assets | 2,395 | 2,275 | 2,325 | 1,911 | 1,922 |
Property, Plant & Equipment | 1,625 | 1,584 | 1,434 | 1,176 | 881.34 |
Long-Term Investments | 789.28 | 515.54 | 404.38 | 347.89 | 188.09 |
Goodwill | 66.56 | 66.56 | 66.56 | 57.6 | 57.6 |
Other Intangible Assets | 393.66 | 412.32 | 450.36 | 275.64 | 126.22 |
Long-Term Deferred Tax Assets | 61.5 | 41.8 | 29.53 | 41.8 | 51.22 |
Long-Term Deferred Charges | 204.8 | 223.28 | 223.8 | 413.28 | 386.18 |
Other Long-Term Assets | 12.15 | 17.15 | 17.1 | 34.41 | 56.81 |
Total Assets | 5,548 | 5,135 | 4,951 | 4,257 | 3,669 |
Accounts Payable | 252.28 | 215.02 | 211.7 | 151.01 | 141.11 |
Accrued Expenses | 255.35 | 238.6 | 328.25 | 240.6 | 306.76 |
Short-Term Debt | - | 5 | - | 3 | - |
Current Portion of Leases | 7.66 | 10.71 | 8.81 | 6.08 | 3.3 |
Current Income Taxes Payable | 56.39 | 58.22 | 43.91 | 46.88 | 93.12 |
Current Unearned Revenue | 8.09 | 19.34 | 24.43 | 27.96 | 19.51 |
Other Current Liabilities | 59.93 | 120.69 | 229.98 | 200.27 | 62.99 |
Total Current Liabilities | 639.7 | 667.59 | 847.08 | 675.8 | 626.79 |
Long-Term Leases | 25.29 | 38.25 | 47.82 | 24.06 | 23.74 |
Long-Term Unearned Revenue | 123.43 | 121.53 | 113.52 | 114.16 | 107.18 |
Long-Term Deferred Tax Liabilities | 20.57 | 8.05 | 10.01 | 41.14 | 7.81 |
Other Long-Term Liabilities | 2.31 | - | - | - | - |
Total Liabilities | 811.3 | 835.41 | 1,018 | 855.17 | 765.52 |
Common Stock | 1,673 | 1,673 | 1,677 | 1,673 | 1,638 |
Additional Paid-In Capital | 459.5 | 508.66 | 519.82 | 405.73 | 186.87 |
Retained Earnings | 2,376 | 2,058 | 1,767 | 1,337 | 961.26 |
Treasury Stock | -14.55 | -114.57 | -226.22 | -207.41 | - |
Comprehensive Income & Other | 64.76 | - | - | - | - |
Total Common Equity | 4,558 | 4,124 | 3,737 | 3,209 | 2,787 |
Minority Interest | 178.34 | 175.63 | 194.93 | 193.09 | 116.97 |
Shareholders' Equity | 4,736 | 4,300 | 3,932 | 3,402 | 2,904 |
Total Liabilities & Equity | 5,548 | 5,135 | 4,951 | 4,257 | 3,669 |
Total Debt | 32.96 | 53.96 | 56.63 | 33.14 | 27.04 |
Net Cash (Debt) | 1,550 | 1,390 | 1,399 | 1,134 | 1,101 |
Net Cash Growth | 11.54% | -0.66% | 23.35% | 3.03% | 25.04% |
Net Cash Per Share | 0.93 | 0.83 | 0.84 | 0.69 | 0.69 |
Filing Date Shares Outstanding | 1,666 | 1,678 | 1,661 | 1,589 | 1,638 |
Total Common Shares Outstanding | 1,666 | 1,678 | 1,661 | 1,589 | 1,638 |
Working Capital | 1,755 | 1,608 | 1,478 | 1,235 | 1,295 |
Book Value Per Share | 2.74 | 2.46 | 2.25 | 2.02 | 1.70 |
Tangible Book Value | 4,098 | 3,645 | 3,220 | 2,875 | 2,603 |
Tangible Book Value Per Share | 2.46 | 2.17 | 1.94 | 1.81 | 1.59 |
Buildings | 767.14 | 545.04 | 583.06 | 564.87 | 469.79 |
Machinery | 809.14 | 760.51 | 624.66 | 562.37 | 528.17 |
Construction In Progress | 620.77 | 799.75 | 672.51 | 445.68 | 228.75 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.